Patent · US Active

Piperidine derivatives as orexin receptor antagonist

US10100047B2 · kind B2 · utility

4Cited by

0References

10Claims

0Family size

Assignees

Inventors

Haiying He · Shanghai, CN
Songliang Wu · Shanghai, CN
Yang Zhang · San Diego, US
Biao Ma · Sunnyvale, US
Yuan Chen · Shanghai, CN
Yuhe Wang · Ann Arbor, US
Shuhui CHEN · Shanghai, CN
Qiang Lv · Shanghai, CN
Jiong Lan · Moraga, US
Xing Liu · Hefei, CN

Key dates

Filing date	Feb 27, 2015
Grant date	Oct 16, 2018
Priority date	—
Expiry date	Feb 27, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses a series of piperidine derivatives as orexin receptor antagonists and compositions thereof, and relates to the application thereof in preparing medications for the treatment of insomnia, chronic obstructive pulmonary disease, obstructive sleep apnea, hypersomnia, anxiety, obsessive-compulsive disorder, panic attack, nicotine addiction, or binge eating disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.